Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GSR | P00390 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17246090 | 0.95 | CNR1 (0.37) | CNR1CNR2TDP1L3MBTL1GSR | |
| SCHEMBL22192281 | 0.94 | ALDH1A1 (0.34) | CNR1CNR2TDP1L3MBTL1MEN1 | |
| SCHEMBL18620716 | 0.93 | KDM4E (0.37) | CNR1CNR2TDP1L3MBTL1GSR | |
| SCHEMBL16482069 | 0.93 | CNR1 (0.34) | CNR1CNR2TDP1L3MBTL1GSR | |
| SCHEMBL18620723 | 0.92 | ALOX5 (0.33) | CNR1CNR2ALOX5 | |
| SCHEMBL18620738 | 0.92 | ALOX5 (0.33) | CNR1CNR2ALOX5 | |
| SCHEMBL18620745 | 0.92 | TDP1 (0.31) | CNR1CNR2TDP1 | |
| SCHEMBL18619022 | 0.91 | PDE6D (0.32) | CNR1CNR2ALOX5 | |
| SCHEMBL18619072 | 0.91 | TDP1 (0.30) | CNR1CNR2TDP1L3MBTL1 | |
| SCHEMBL18620388 | 0.90 | TDP1 (0.32) | CNR1CNR2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10703762-B2 | Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus | IDEMITSU KOSAN CO., LTD. (JP) | 2020-07-07 | — | — | US | disclosed |
| WO-2017038728-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | 出光興産株式会社 | 2017-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10703762-B2 | Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus | PIEZO1, OR10J3, EPCAM | CNR1 3757/4885CNR2 4320/4885TDP1 3410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.